Literature DB >> 8521619

Oncogene-dependent expression of CD44 in Balb/c 3T3 derivatives: correlation with metastatic competence.

P Kogerman1, M S Sy, L A Culp.   

Abstract

Oncogene-dependent regulation and tumor relatedness of CD44 expression were investigated in Balb/c 3T3 cells and their derivatives transformed with different ras oncogenes (metastatic tumor model) or the human c-sis oncogene (non-metastatic model). Ras transformants using either the Harvey or Kirsten oncogenes expressed high levels of cell surface CD44 protein that bound fluoresceinated hyaluronan (HA). Much lower levels of CD44 were expressed in parental 3T3 cells, ras- revertants generated from Kirsten-transformed cells, or c-sis transformants, confirming the significance of the ras oncogene in this upregulation. To determine whether endogenous HA regulates these parameters, hyaluronidase treatment of ras transformants exposed more cell surface CD44 to anti-CD44 antibody and increased fluoresceinated HA binding; this did not occur with 3T3 or c-sis transformants. CD44 expression and its HA-binding function were conserved in a panel of in vivo primary and lung metastatic tumor cell lines derived from ras transformants. Ras transformants also retained the ability to downregulate CD44 protein levels in confluent cultures which occurred through a translational or post-translational mechanism (as CD44 mRNA levels were not reduced). These results taken together demonstrate that ras-dependent regulation of CD44 may correlate with tumor progression and metastasis in vivo, possibly (although not exclusively) supporting CD44's importance in metastatic progression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8521619     DOI: 10.1007/bf00157688

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  36 in total

1.  Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.

Authors:  M Culty; M Shizari; E W Thompson; C B Underhill
Journal:  J Cell Physiol       Date:  1994-08       Impact factor: 6.384

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior.

Authors:  W Rudy; M Hofmann; R Schwartz-Albiez; M Zöller; K H Heider; H Ponta; P Herrlich
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

4.  Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.

Authors:  Y J Guo; J Ma; J H Wong; S C Lin; H C Chang; M Bigby; M S Sy
Journal:  Cell Immunol       Date:  1993-11       Impact factor: 4.868

5.  Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression.

Authors:  R Radinsky; P M Kraemer; M A Raines; H J Kung; L A Culp
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells.

Authors:  H H Jamal; D F Cano-Gauci; R N Buick; J Filmus
Journal:  Oncogene       Date:  1994-02       Impact factor: 9.867

Review 7.  Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites.

Authors:  G L Nicolson
Journal:  Cancer Metastasis Rev       Date:  1988-06       Impact factor: 9.264

8.  Complementation of two related tumour cell classes during experimental metastasis tagged with different histochemical marker genes.

Authors:  W C Lin; K L O'Connor; L A Culp
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

9.  Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.

Authors:  K Miyake; C B Underhill; J Lesley; P W Kincade
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  Distinct effects of two CD44 isoforms on tumor growth in vivo.

Authors:  M S Sy; Y J Guo; I Stamenkovic
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  6 in total

1.  CD44 isoform expression in the diffuse neuroendocrine system. I. Normal cells and hyperplasia.

Authors:  W K Seelentag; P Komminoth; P Saremaslani; P U Heitz; J Roth
Journal:  Histochem Cell Biol       Date:  1996-12       Impact factor: 4.304

Review 2.  CD44 in inflammation and metastasis.

Authors:  J Lesley; R Hyman; N English; J B Catterall; G A Turner
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

3.  Overexpressed human CD44s promotes lung colonization during micrometastasis of murine fibrosarcoma cells: facilitated retention in the lung vasculature.

Authors:  P Kogerman; M S Sy; L A Culp
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

Review 4.  CD44 cell adhesion molecules.

Authors:  S Goodison; V Urquidi; D Tarin
Journal:  Mol Pathol       Date:  1999-08

5.  Over-expression of human CD44s in murine 3T3 cells: selection against during primary tumorigenesis and selection for during micrometastasis.

Authors:  P Kogerman; M S Sy; L A Culp
Journal:  Clin Exp Metastasis       Date:  1998-01       Impact factor: 5.150

6.  CD44 expression in pleomorphic adenoma, carcinoma ex pleomorphic adenoma and their adjacent normal salivary glands.

Authors:  Nafiseh Shamloo; Nasim Taghavi; Farzad Yazdani; Soudeh Shalpoush; Samane Ahmadi
Journal:  Dent Res J (Isfahan)       Date:  2018 Sep-Oct
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.